Toll Free: 1-888-928-9744
Published: Dec, 2016 | Pages:
49 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Biomar Microbial Technologies - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'Biomar Microbial Technologies - Product Pipeline Review - 2016', provides an overview of the Biomar Microbial Technologies's pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Biomar Microbial Technologies, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Biomar Microbial Technologies - The report provides overview of Biomar Microbial Technologies including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Biomar Microbial Technologies's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Biomar Microbial Technologies's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons To Buy - Evaluate Biomar Microbial Technologies's strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Biomar Microbial Technologies - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Biomar Microbial Technologies's pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 5 Introduction 6 Global Markets Direct Report Coverage 6 Biomar Microbial Technologies Snapshot 7 Biomar Microbial Technologies Overview 7 Key Facts 7 Biomar Microbial Technologies - Research and Development Overview 8 Key Therapeutic Areas 8 Biomar Microbial Technologies - Pipeline Review 11 Pipeline Products by Stage of Development 11 Pipeline Products - Monotherapy 12 Biomar Microbial Technologies - Pipeline Products Glance 13 Biomar Microbial Technologies - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Discovery Products/Combination Treatment Modalities 14 Biomar Microbial Technologies - Drug Profiles 15 IB-05202 - Drug Profile 15 Product Description 15 Mechanism Of Action 15 R&D Progress 15 IB-06202 - Drug Profile 16 Product Description 16 Mechanism Of Action 16 R&D Progress 16 IB-07A037 - Drug Profile 17 Product Description 17 Mechanism Of Action 17 R&D Progress 17 IB-07A081 - Drug Profile 18 Product Description 18 Mechanism Of Action 18 R&D Progress 18 IB-07A085 - Drug Profile 19 Product Description 19 Mechanism Of Action 19 R&D Progress 19 IB-08C175 - Drug Profile 20 Product Description 20 Mechanism Of Action 20 R&D Progress 20 IB-08C179 - Drug Profile 21 Product Description 21 Mechanism Of Action 21 R&D Progress 21 IB-09A0133 - Drug Profile 22 Product Description 22 Mechanism Of Action 22 R&D Progress 22 IB-09A149 - Drug Profile 23 Product Description 23 Mechanism Of Action 23 R&D Progress 23 IB-10A111 - Drug Profile 24 Product Description 24 Mechanism Of Action 24 R&D Progress 24 IB-10C179 - Drug Profile 25 Product Description 25 Mechanism Of Action 25 R&D Progress 25 IB-12A157 - Drug Profile 26 Product Description 26 Mechanism Of Action 26 R&D Progress 26 Small Molecule 1 for Oncology - Drug Profile 27 Product Description 27 Mechanism Of Action 27 R&D Progress 27 Small Molecule 2 for Oncology - Drug Profile 28 Product Description 28 Mechanism Of Action 28 R&D Progress 28 Small Molecule 3 for Oncology - Drug Profile 29 Product Description 29 Mechanism Of Action 29 R&D Progress 29 Small Molecules 4 for Oncology - Drug Profile 30 Product Description 30 Mechanism Of Action 30 R&D Progress 30 Small Molecules for Aspergillosis and Candidiasis - Drug Profile 31 Product Description 31 Mechanism Of Action 31 R&D Progress 31 Small Molecules for Bacterial Infections - Drug Profile 32 Product Description 32 Mechanism Of Action 32 R&D Progress 32 Small Molecules for Glioblastoma - Drug Profile 33 Product Description 33 Mechanism Of Action 33 R&D Progress 33 Small Molecules for Multi Drug Resistant Staphylococcus Aureus Infections - Drug Profile 34 Product Description 34 Mechanism Of Action 34 R&D Progress 34 Small Molecules for Neuropathic Pain - Drug Profile 35 Product Description 35 Mechanism Of Action 35 R&D Progress 35 Small Molecules for Tuberculosis - Drug Profile 36 Product Description 36 Mechanism Of Action 36 R&D Progress 36 Small Molecules to Antagonize G-Protein-Coupled Receptors for Oncology - Drug Profile 37 Product Description 37 Mechanism Of Action 37 R&D Progress 37 Small Molecules to Antagonize VEGF Receptor for Oncology - Drug Profile 38 Product Description 38 Mechanism Of Action 38 R&D Progress 38 Small Molecules to Inhibit Kinase for Oncology - Drug Profile 39 Product Description 39 Mechanism Of Action 39 R&D Progress 39 Small Molecules to Inhibit NIK for Multiple Sclerosis - Drug Profile 40 Product Description 40 Mechanism Of Action 40 R&D Progress 40 Small Molecules to Inhibit tRNA for Bacterial Infections - Drug Profile 41 Product Description 41 Mechanism Of Action 41 R&D Progress 41 Biomar Microbial Technologies - Pipeline Analysis 42 Biomar Microbial Technologies - Pipeline Products by Target 42 Biomar Microbial Technologies - Pipeline Products by Route of Administration 43 Biomar Microbial Technologies - Pipeline Products by Molecule Type 44 Biomar Microbial Technologies - Pipeline Products by Mechanism of Action 45 Biomar Microbial Technologies - Dormant Projects 46 Biomar Microbial Technologies - Locations And Subsidiaries 47 Head Office 47 Appendix 48 Methodology 48 Coverage 48 Secondary Research 48 Primary Research 48 Expert Panel Validation 48 Contact Us 48 Disclaimer 49
List of Tables Biomar Microbial Technologies, Key Facts 7 Biomar Microbial Technologies - Pipeline by Indication, 2016 9 Biomar Microbial Technologies - Pipeline by Stage of Development, 2016 11 Biomar Microbial Technologies - Monotherapy Products in Pipeline, 2016 12 Biomar Microbial Technologies - Preclinical, 2016 13 Biomar Microbial Technologies - Discovery, 2016 14 Biomar Microbial Technologies - Pipeline by Target, 2016 42 Biomar Microbial Technologies - Pipeline by Route of Administration, 2016 43 Biomar Microbial Technologies - Pipeline by Molecule Type, 2016 44 Biomar Microbial Technologies - Pipeline Products by Mechanism of Action, 2016 45 Biomar Microbial Technologies - Dormant Developmental Projects,2016 46
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.